Browsing by Author O'Neill, SM

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 6 to 14 of 14< previous 
Issue DateTitleAuthor(s)
1-Nov-2008Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophagesDonnelly, S; Stack, CM; O'Neill, SM; Sayed, AA; Williams, DL; Dalton, JP
29-Jan-2010Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3Donnelly, S; O'Neill, SM; Stack, CM; Robinson, MW; Turnbull, L; Whitchurch, C; Dalton, JP
1-Jan-2003Helminth vaccines: From mining genomic information for vaccine targets to systems used for protein expressionDalton, JP; Brindley, PJ; Knox, DP; Brady, CP; Hotez, PJ; Donnelly, S; O'Neill, SM; Mulcahy, G; Loukas, A
1-Aug-2013Immunomodulatory molecules of Fasciola hepatica: Candidates for both vaccine and immunotherapeutic developmentDalton, JP; Robinson, MW; Mulcahy, G; O'Neill, SM; Donnelly, S
1-Apr-2018Infection by the helminth parasite fasciola hepatica requires rapid regulation of metabolic, virulence, and invasive factors to adjust to its mammalian hostCwiklinski, K; Jewhurst, H; McVeigh, P; Barbour, T; Maule, AG; Tort, J; O'Neill, SM; Robinson, MW; Donnelly, S; Dalton, JP
1-Feb-2010Major secretory antigens of the Helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responsesDowling, DJ; Hamilton, CM; Donnelly, S; La Course, J; Brophy, PM; Dalton, J; O'Neill, SM
23-Aug-2012Mechanisms of Immune Modulation by Fasciola hepatica: Importance for Vaccine Development and for Novel ImmunotherapeuticsRobinson, MW; Dalton, JP; O'Neill, SM; Donnelly, SM
1-Sep-2016A prospective view of animal and human FasciolosisCwiklinski, K; O'Neill, SM; Donnelly, S; Dalton, JP
1-Jan-2005Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophagesDonnelly, S; O'Neill, SM; Sekiya, M; Mulcahy, G; Dalton, JP